Literature DB >> 6652357

The relative significance of spinal and supraspinal actions in the antinociceptive effect of morphine in the dorsal horn: an evaluation of the microinjection technique.

S L Clark, R O Edeson, R W Ryall.   

Abstract

Large quantities of morphine injected directly into the brainstem of spinal anaesthetized cats inhibited the noxious heat-evoked excitation of dorsal horn neurones. The amounts required were similar to those that were required intravenously in cats with the spinal cord intact or transected. When the spinal cord was intact the amount of morphine microinjected into the brainstem required to inhibit the excitation of dorsal horn neurones was about ten fold less than it was in spinal animals. It is concluded that large, but not small doses of morphine microinjected into the brainstem can exert effects on the spinal cord after first entering the circulation. The effects of small doses are attributed to a local action in the brainstem which causes inhibition of spinal neurones either by activating descending inhibitory neuronal systems or by liberating endogenous substances which reach the spinal cord via the cerebro-spinal fluid. The concentrations of morphine achieved at various distances from the site of injection by the microinjection of microgram quantities and the time courses of the concentration changes were calculated from diffusion equations, assuming diffusion coefficients of 3 or 5 X 10(6) cm2 s-1. The curves obtained closely approximated those obtained experimentally. The concentrations achieved at distances up to 2 mm from the site of injection of 10 micrograms of morphine were calculated to exceed 10(-4)M and the time-courses of these concentration changes were compatible with the time course of inhibition of spinal neurones, or the production of analgesia after microinjection. Such concentrations are vastly in excess of those achieved in the brain after the systemic administration of morphine in analgesic doses. It is concluded that the local effects in the brainstem produced by the microinjection of microgram quantities of morphine have no relevance to the mechanism of analgesia produced by systemic administration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652357      PMCID: PMC2044908          DOI: 10.1111/j.1476-5381.1983.tb10019.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet implanted mice.

Authors:  G A Patrick; W L Dewey; T C Spaulding; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1975-06       Impact factor: 4.030

2.  Role of noradrenaline and serotonin in the central control of blood pressure in normotensive and spontaneously hypertensive rats.

Authors:  W de Jong; F P Nijkamp; B Bohus
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-02

3.  Clonidine-induced cardiovascular effects after stereotaxic application in the hypothalamus of rats.

Authors:  H A Boudier; J M van Rossum
Journal:  J Pharm Pharmacol       Date:  1972-05       Impact factor: 3.765

4.  Sites of morphine induced analgesia in the primate brain: relation to pain pathways.

Authors:  A Pert; T Yaksh
Journal:  Brain Res       Date:  1974-11-08       Impact factor: 3.252

5.  Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat.

Authors:  L G Sharpe; J E Garnett; T J Cicero
Journal:  Behav Biol       Date:  1974-07

6.  Effects of morphine and naloxone on dorsal horn neurones in the cat.

Authors:  O Calvillo; J L Henry; R S Neuman
Journal:  Can J Physiol Pharmacol       Date:  1974-12       Impact factor: 2.273

7.  Lamina-specific suppression of dorsal-horn unit activity by morphine sulfate.

Authors:  L M Kitahata; Y Kosaka; A Taub; K Bonikos; M Hoffert
Journal:  Anesthesiology       Date:  1974-07       Impact factor: 7.892

8.  Depressive effects of morphine upon lamina V cells activities in the dorsal horn of the spinal cat.

Authors:  D Le Bars; D Menétrey; C Conseiller; J M Besson
Journal:  Brain Res       Date:  1975-11-14       Impact factor: 3.252

9.  The distribution of morphine following intracerebral microinjection.

Authors:  P Lomax
Journal:  Experientia       Date:  1966-04-15

10.  Drinking induced by injection of angiotensin into the rain of the rat.

Authors:  A N Epstein; J T Fitzsimons; B J Rolls
Journal:  J Physiol       Date:  1970-09       Impact factor: 5.182

View more
  6 in total

Review 1.  Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat.

Authors:  A H Dickenson; D Le Bars
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

2.  Opiates distinguish spinal excitation from inhibition evoked by noxious heat stimuli in the rat: relevance to theories of analgesia.

Authors:  N C Harris; R W Ryall
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

3.  μ-Opioid receptors in primary sensory neurons are involved in supraspinal opioid analgesia.

Authors:  Jie Sun; Shao-Rui Chen; Hui-Lin Pan
Journal:  Brain Res       Date:  2019-12-24       Impact factor: 3.252

4.  Antinociception from a stereospecific action of morphine microinjected into the brainstem: a local or distant site of action?

Authors:  W A Prado; M H Roberts
Journal:  Br J Pharmacol       Date:  1984-08       Impact factor: 8.739

5.  The effects of methyl beta-carboline-3-carboxylate on social interaction and locomotor activity when microinjected into the nucleus raphé dorsalis of the rat.

Authors:  S W Hindley; A Hobbs; I A Paterson; M H Roberts
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

6.  A numerical investigation of intrathecal isobaric drug dispersion within the cervical subarachnoid space.

Authors:  Per Thomas Haga; Giulia Pizzichelli; Mikael Mortensen; Miroslav Kuchta; Soroush Heidari Pahlavian; Edoardo Sinibaldi; Bryn A Martin; Kent-Andre Mardal
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.